To push the frontiers of diabetes and obesity treatments, the US-based headquarters of Australian RNAi specialist Benitec recently signed an exclusive licensing agreement with the Garvan Institute of Medical Research, based in Sydney, Australia.
Nanotechnology and materials specialist NanoHorizons announced early in February that it had been issued a patent for its deposited thin-film system, QuickMass, for high-throughput small-molecule MS.
In late January, Thermo Electron announced that it would dramatically enhance its product portfolio by acquiring Kendro Laboratory Products, a division of SPX Corp.
In an effort to become a one-stop-shop to clients, DNA sequencing specialist Agencourt Bioscience and genomic library producer Amplicon Express announced they formed a strategic marketing alliance.
Recent efforts by researchers at the WiCell Research Institute may just have put the lid back on the controversy over whether scientists should generate new human embryonic stem (ES) cell lines.
Within a single week, two major players in the drug discovery instrumentation and reagent industry—Thermo Electron and Invitrogen—made moves to capitalize on the ever-strengthening Chinese biotechnology and pharmaceutical markets, further entrenching the
With the recent launch of the multidisciplinary Metrology for Gene Expression Program, the National Institute of Standards and Technology (NIST) is hoping to explore and address the challenges associated with the measurement, validation, and quality contr
The lab-on-a-chip (LOC) field may be about to hit its stride with the recent introduction of a fully automated system by Agilent Technologies. Designed to replace gel electrophoresis steps, the Agilent 5100 ALP allows researchers to perform thousands of u
In late 2004, Bookham New Focus introduced the Clarity line of fluorescence filters, developed for use in analytical and diagnostic instruments, including fluorescence microscopy, flow cytometry, DNA sequencing, microarrays, and other fluorescence applica
The Biotechnology Greenhouse of Southeastern Pennsylvania BioAdvance recently announced the selection of Dr. Michael Pellini as the organization’s inaugural Entrepreneur-in-Residence. Part of a $2-billion initiative by the Commonwealth of Pennsylvania to
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.